| Rapid synthesis of auxin via a new tryptophan-dependent pathway is required for shade avoidance in plants Y Tao, JL Ferrer, K Ljung, F Pojer, F Hong, JA Long, L Li, JE Moreno, ... Cell 133 (1), 164-176, 2008 | 1183 | 2008 |
| Different plant hormones regulate similar processes through largely nonoverlapping transcriptional responses JL Nemhauser, F Hong, J Chory Cell 126 (3), 467-475, 2006 | 1063 | 2006 |
| Signals from chloroplasts converge to regulate nuclear gene expression S Koussevitzky, A Nott, TC Mockler, F Hong, G Sachetto-Martins, M Surpin, ... Science 316 (5825), 715-719, 2007 | 955 | 2007 |
| RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis F Hong, R Breitling, CW McEntee, BS Wittner, JL Nemhauser, J Chory Bioinformatics 22 (22), 2825-2827, 2006 | 858 | 2006 |
| Network discovery pipeline elucidates conserved time-of-day–specific cis-regulatory modules TP Michael, TC Mockler, G Breton, C McEntee, A Byer, JD Trout, ... PLoS genetics 4 (2), e14, 2008 | 574 | 2008 |
| Molecular mechanisms of steroid hormone signaling in plants G Vert, JL Nemhauser, N Geldner, F Hong, J Chory Annu. Rev. Cell Dev. Biol. 21, 177-201, 2005 | 456 | 2005 |
| Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated … LI Gordon, F Hong, RI Fisher, NL Bartlett, JM Connors, RD Gascoyne, ... Journal of Clinical Oncology 31 (6), 684, 2013 | 334 | 2013 |
| A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments F Hong, R Breitling Bioinformatics 24 (3), 374-382, 2008 | 300 | 2008 |
| Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy … FJ Giles, MJ Mauro, F Hong, CE Ortmann, C McNeill, RC Woodman, ... Leukemia 27 (6), 1310-1315, 2013 | 256 | 2013 |
| Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial KL Tan, DW Scott, F Hong, BS Kahl, RI Fisher, NL Bartlett, RH Advani, ... Blood, The Journal of the American Society of Hematology 120 (16), 3280-3287, 2012 | 249 | 2012 |
| Rituximab extended schedule or re-treatment trial for low–tumor burden follicular lymphoma: Eastern Cooperative Oncology Group protocol E4402 BS Kahl, F Hong, ME Williams, RD Gascoyne, LI Wagner, JC Krauss, ... Journal of Clinical Oncology 32 (28), 3096, 2014 | 226 | 2014 |
| Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial DL Berry, F Hong, B Halpenny, AH Partridge, JR Fann, S Wolpin, ... Journal of Clinical Oncology 32 (3), 199, 2014 | 213 | 2014 |
| Gene expression–based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma DW Scott, FC Chan, F Hong, S Rogic, KL Tan, B Meissner, S Ben-Neriah, ... Journal of Clinical Oncology 31 (6), 692, 2013 | 194 | 2013 |
| Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenström macroglobulinemia IM Ghobrial, F Hong, S Padmanabhan, A Badros, M Rourke, R Leduc, ... Journal of Clinical Oncology 28 (8), 1422, 2010 | 184 | 2010 |
| Threats of bots and other bad actors to data quality following research participant recruitment through social media: Cross-sectional questionnaire R Pozzar, MJ Hammer, M Underhill-Blazey, AA Wright, JA Tulsky, F Hong, ... Journal of medical Internet research 22 (10), e23021, 2020 | 179 | 2020 |
| Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial JA Kanakry, H Li, LL Gellert, MV Lemas, W Hsieh, F Hong, KL Tan, ... Blood, The Journal of the American Society of Hematology 121 (18), 3547-3553, 2013 | 157 | 2013 |
| Subset of heat-shock transcription factors required for the early response of Arabidopsis to excess light HS Jung, PA Crisp, GM Estavillo, B Cole, F Hong, TC Mockler, BJ Pogson, ... Proceedings of the National Academy of Sciences 110 (35), 14474-14479, 2013 | 148 | 2013 |
| Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia IM Ghobrial, A Roccaro, F Hong, E Weller, N Rubin, R Leduc, M Rourke, ... Clinical Cancer Research 16 (3), 1033-1041, 2010 | 142 | 2010 |
| The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and S tanford V in older H odgkin lymphoma patients: a comprehensive analysis from the N orth A … AM Evens, F Hong, LI Gordon, RI Fisher, NL Bartlett, JM Connors, ... British journal of haematology 161 (1), 76-86, 2013 | 140 | 2013 |
| Phase II study of AZD4547 in patients with tumors harboring aberrations in the FGFR pathway: results from the NCI-MATCH trial (EAY131) subprotocol W YK Chae, F Hong, C Vaklavas, HH Cheng, P Hammerman, EP Mitchell, ... Journal of Clinical Oncology 38 (21), 2407, 2020 | 120 | 2020 |
